Indian COVID-19 diagnostic market will see the declined growth of 19.9% during the forecast period. India has significant scope for COVID-19 diagnostic owing to robust increase in the diagnostic tests in the country coupled with the growing number of positive COVID-19 cases. The Indian government expanded the network of government laboratories designated to test samples of suspected COVID-19 cases to 920 laboratories. Moreover, the government of the respective states are taking several steps to contain the spread of COVID-19. For instance, in June 2020, Uttar Pradesh Government announced to start an antigen test for identification of COVID patients. It is a test on swab-based nasal samples which gives early results and is very different from the Rapid Antibody Test, which tests blood samples for the presence of antibodies against the virus which causes COVID-19. In the first phase, the antigen tests will start in five cities Lucknow, Prayagraj, Varanasi, Gorakhpur and Kanpur. Later it will be introduced in the districts of western part of the state.
Browse the full report description India COVID-19 Diagnostics Market Size, Share & Trends Analysis Report by Type (Instruments, Reagents & Kits, and Laboratory Testing Services), by Technology Type (PCR Test, Antigen Test, Serology Test, and Rapid/ PoC Test), by Sample Type (Oropharyngeal & Nasopharyngeal Swabs, Blood, Urine, Saliva, and Others), and by End-User (Laboratories, Hospitals, Diagnostic Centers & Clinics, and Research Institutes) and Forecast, 2020-2026 at https://www.omrglobal.com/industry-reports/india-covid-19-diagnostics-market
In June 2020, ICMR and AIIMS, Delhi independently evaluated the stand-alone rapid PoC antigen detection assay which does not require a specialized machine and can be interpreted with a naked eye. The test is a promising tool for quick diagnosis of SARS-CoV-2 in field settings. The assay is known as Standard Q COVID-19 Ag kit and has been developed by SD Biosensor with manufacturing unit at Manesar, Gurugram. On validation, the test has been found to have a very high specificity with moderate sensitivity. It is now recommended to use Standard Q COVID-19 Ag detection test as a PoC diagnostic assay for testing in the containment zones as well as hospitals in combination with the gold standard RT-PCR test. Therefore, the introduction of these type of rapid test in the country further escalated the diagnosis rates in the country that further propels the market growth.
Market Coverage
|
Report Elements |
Details |
|
Study Period |
2020-2026 |
|
Segments Covered |
By Type, By Technology Type, By Sample Type, and By End-Users |
|
Key Companies Profiled |
Biogenix Inc. Pvt. Ltd.,
BioGenomics Ltd., J Mitra & Co. Pvt Ltd., Mylab Discovery Solutions Pvt
Ltd., and Aspen Laboratories Pvt. Ltd. |
Key questions addressed by the report
o Recovery Timeline
o Deviation from pre-COVID
o Most affected segment
o Recommendations
Indian COVID-19 Diagnostics Market – Segmentation
By Type
By Technology Type
o Chromatographic Immunoassay
o Fluorescent Immunoassay
o Chemiluminescent Immunoassay
o Enzyme-Linked Immunosorbent Assay (ELISA)
o Neutralization
o Chemiluminescent Immunoassay
By Sample Type
By End-Users
To learn more about this report request a free sample copy
@ https://www.omrglobal.com/request-sample/india-covid-19-diagnostics-market